TORONTO, Feb. 4, 2021 /PRNewswire/ – Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN) (OTCQX: KHRNF) (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is happy to announce that Alvaro Torres, Khiron CEO and manager, along side users of this Khiron administration group, will host a real time webcast on Wednesday, February 17 at 11:00am ET to go over current outcomes and management’s perspective for 2021.
Management may also be hosting a 1×1 Virtual Roadshow with Harbor Access February 9-10, 2021 and taking part in the Benzinga Virtual Cannabis Capital Conference being held February 25-26, 2021. In addition, Mr. Torres will likely to be taking part in the Benzinga Cannabis Hour on Thursday, February 11, 2021 as a panelist speaking about the worldwide cannabis landscape.
Khiron Investor Day Webcast: 2021 Outlook
Date: Wednesday, February 17, 2021
Time: 11:00am-12:00pm ET
To register: https://event.on24.com/wcc/r/3002371/132B51F89A277D8D1AADD6CDB47FD509
Harbor Access 1×1 Virtual Roadshow
Date: February 9-10, 2021
To register: Email [email protected] to book 1×1 meeting
Benzinga Cannabis Hour: Overseas Cannabis
Date: Thursday, February 11 at 4pm ET
To attend: http*)Benzinga that is://bzcannabishour.com Virtual Cannabis Capital Conference
Date: February 25-26, 2021 at 1:30pm ET
To register: https://events.benzinga.com/squeeze-page-422415971607984646162
Recent Company Highlights
- In 2020, achieves 50% compound monthly growth rate (CMGR) in medical cannabis prescriptions (April to December), reaching 7,500 paid prescriptions as of January 31, 2021
- Colombian government extends medical health insurance coverage to THC and CBD medical cannabis products, resulting in strong month-over-month growth in December 2020 and January 2021
- On December 9th, Khiron opens new small-format clinic in Medellin, Colombia’s 2nd city that is largest, within the Company’s intend to expand its medical cannabis clinics across Colombia and Latin America.
- Company appoints previous Colombia Minister of Finance Juan Carlos Echeverry as an unbiased person in its Board of Directors
- Khiron declared a National Strategic venture by the us government of Colombia, which simplifies and accelerates management procedures for the Company’s strategic initiatives
- Khiron could be the first cannabis business in Colombia to deliver THC services and products internationally
About Khiron Life Sciences Corp.
Khiron is a vertically built-in medical and CPG cannabis business with core operations in Latin America, and activity that is operational Europe and North America. Khiron is the leading medical cannabis provider in Colombia and the first company licensed in Colombia for the cultivation, production, domestic distribution and sales, and international export of both low and high THC medical cannabis products. The Company has filled medical cannabis prescriptions in Colombia, Peru and the UK, and is positioned to commence sales of medical cannabis in Germany and Brazil in early 2021.
Leveraging wholly-owned medical clinics and telemedicine that is proprietary, Khiron combines a patient-oriented approach, doctor training programs, clinical expertise, item innovation, and agricultural infrastructure to push prescriptions and brand name commitment. Its well-being device established the very first branded CBD skincare brand name in Colombia, with KuidaTM now marketed in multiple jurisdictions in Latin America, the usa and British. The organization is led by Co-founder and ceo, Alvaro Torres, along with a skilled and executive that is diverse and Board of Directors.
Visit Khiron online at investors.khiron.ca and on Instagram @khironlife.
This press release may contain certain information that is“forward-looking and “forward-looking statements” inside the meaning of relevant securities legislation. All information contained herein that isn’t historic in nature may represent information that is forward-looking. Khiron undertakes no obligation to comment on analyses, expectations or statements made by third-parties in respect of Khiron, its securities, or financial or operating results (as applicable). Although Khiron believes that the expectations reflected in forward-looking statements in this press release are reasonable, such statement that is forward-looking been centered on objectives, facets and presumptions concerning future activities that might turn out to be inaccurate and therefore are at the mercy of many dangers and uncertainties, specific of that are beyond Khiron’s control, such as the risk facets talked about in Khiron’s Annual Suggestions Form that will be available on Khiron’s SEDAR profile at www.sedar.com. The information that is forward-looking in this press release is expressly qualified by this cautionary statement and is made as of the date hereof. Khiron disclaims any intention and has no obligation or responsibility, except as required by law, to update or revise any information that is forward-looking whether as a consequence of brand new information, future activities or else.
Neither The TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the accuracy or adequacy of this pr release.
Get Real-Time Updates from MJobserver.com